Heidelberg Pharma Research GmbH, a leader in the development of novel antibody-drug conjugates (ADCs) for the treatment of cancer.
Industry: Biotechnology.
Description:
Heidelberg Pharma Research GmbH, a leading company in the development of novel antibody-drug conjugates (ADCs) for the treatment of cancer, commissioned Bradler GmbH to implement SAP Business ByDesign in spring 2016. The aim of the project was to replace existing on-premise solutions and business processes not yet mapped in company software with a uniform, modern cloud ERP for the parent company Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH.
Bradler GmbH provided support in all project phases:
- Creation of the solution design
- Scoping of SAP Business ByDesign
- Training of key users
- Configuration assistance
- Support with data migration
- Support with the go-live and post-go-live support
Heidelberg Pharma Research GmbH and its parent company Heidelberg Pharma AG have been using the SAP Business ByDesign ERP system successfully in all business areas since autumn 2016, from finance to customer relationship management, purchasing, sales and project management. Bradler GmbH will continue to look after the ongoing expansion and optimization of the SAP Business ByDesign ERP system.
Top competencies:
- Problem management
- Communication & reporting
- Price-performance ratio
- Professional qualifications
- Goal-oriented way of working
- reliability
Customer quote:
The Bradler GmbH team impresses with its focus on SAP Business ByDesign, the customer-oriented way of working and the high technical expertise of the consultants. By using SAP Business ByDesign, our business processes are now reliably and transparently mapped in a central system. The positive effects of the implementation became noticeable and measurable after a short time.
Issued for: Bradler GmbH
Issued on: January 18, 2018
Issued by: Marco Schäfer, Head of Controlling
Proof of validity: https://www.trustedreferences.de/referenz/YSG2/1_415/